Cyanide Decorporation by Co(III) Schiff-base Macrocycles
Co(III) 希夫碱大环化合物的氰化物修饰
基本信息
- 批准号:8793566
- 负责人:
- 金额:$ 36.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-30 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAcuteAdolescentAdultAffinityAirAnimal TestingAnimalsAntidotesBehavior assessmentBehavioral AssayBindingBiologicalBlood CirculationCardiacCessation of lifeCharacteristicsClinicCobalaminCobaltComplexControl AnimalCorrinoidsCyanidesDevelopmentDoseEffectivenessElectron Spin Resonance SpectroscopyElectronicsEmergency SituationEquilibriumEuthanasiaExhibitsFDA approvedFemaleGeometryHydrogen SulfideImpairmentIndividualInhalation ExposureIntoxicationIonsLabelLigandsLiteratureMeasurementMeasuresMetalloporphyrinsMetalsMiningMonitorMusMusculoskeletalNeurologicNitrogenPoisoningPorphyrinsPositioning AttributeProceduresProductionPuncture procedureReactionRecoveryReportingRotarod Performance TestSaltsSchiff BasesSolubilitySpectrophotometryStructureSystemTestingTimeTitrationsToxic effectToxinTriageWaterWeightWhole Bloodabsorptionbiophysical propertiescircular magnetic dichroismcobinamidedaltonexperiencefootimprovedknock-downmass casualtyoxidationpregnantpreventpublic health relevanceresearch studysmoke inhalationweapons
项目摘要
DESCRIPTION (provided by applicant): Drawing on past experience of gaseous HCN poisoning through smoke inhalation, it is clear that many treatable individuals (mass casualties) will present at triage more than 30 min after exposure still exhibiting signs of acute cyanide toxicity. Compounds that lower the circulating level of free cyanide in the bloodstream have been shown to be effective antidotes to cyanide poisoning in such cases. Cobalamin is currently the only FDA-approved cyanide-binding coordination compound available as an antidote for emergency and clinic use, but it is far from ideal and expensive. We have very recently shown that a cobalt(III)-containing water-soluble porphyrin, exhibiting better cyanide-binding capability
than cobalamin, functions as a cyanide antidote in mice [Benz et al (2012) Chem Res Tox, 25, 2678-86]. We hypothesize that many compounds in which cobalt(III) is surrounded by a square-planar arrangement of nitrogen-donors with two labile ligands in the axial positions are good candidate antidotes for cyanide (and hydrogen sulfide) poisoning. The syntheses of numerous simpler (less expensive) complexes of cobalt(III) having this necessary surrounding ligand geometry have been reported and many more are accessible by trivial derivatization of compounds reported in the existing inorganic literature. Macrocyclic complexes, in which the cobalt(III) ion is retained by a chelate ring, are expected to be non-toxic at the levels required o be efficacious in treating cyanide intoxication. Aim 1. To synthesize, by exploiting the existing literature, a small number of cobalt(III)-containing Schiff-base macrocycles (3 to 6) and determine the cyanide-binding characteristics of these compounds. Aim 2. To demonstrate that the cobalt(III)-containing Schiff-base macrocycles are effective antidotes to cyanide intoxication in mice. A variety of biophysical measurements and behavioral assays will be used to assess the effectiveness of the candidate compounds as cyanide- scavenging agents.
描述(由申请人提供):根据过去通过烟雾吸入引起的气态HCN中毒的经验,很明显,许多可治疗的个人(大量伤亡)在暴露后30分钟以上的分诊时仍显示出急性氰化物中毒的迹象。在这种情况下,降低血液中游离氰化物循环水平的化合物已被证明是有效的氰化物中毒解毒剂。钴胺目前是FDA批准的唯一一种氰化物结合的配位化合物,可用作紧急和临床解毒剂,但它远不理想,也很昂贵。我们最近发现了一种含钴(III)的水溶性卟啉,表现出更好的氰化物结合能力
与钴胺相比,它在小鼠中具有氰化物解毒剂的作用[Benz等人(2012)Chem res Tox,25,2678-86]。我们假设,许多钴(III)被正方形平面排列的氮供体包围的化合物是氰化物(和硫化氢)中毒的很好的候选解毒剂。已有报道合成了许多更简单(不太昂贵)的钴(III)配合物,它们具有这种必需的周围配体构型,更多的化合物可以通过现有无机文献中报道的化合物的简单衍生化来获得。大环络合物中的钴(III)离子被一个螯合环保留,预计在有效治疗氰化物中毒所需的水平上是无毒的。目的1.利用已有文献合成少量含钴(III)席夫碱大环(3~6个),并测定这些化合物的氰化物结合特性。目的2.证明含钴(III)席夫碱大环化合物是小鼠氰化物中毒的有效解毒剂。将使用各种生物物理测量和行为分析来评估候选化合物作为氰化物清除剂的有效性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LINDA L PEARCE其他文献
LINDA L PEARCE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LINDA L PEARCE', 18)}}的其他基金
Nitrites as Antidotes for Hydrogen Sulfide Poisoning
亚硝酸盐作为硫化氢中毒的解毒剂
- 批准号:
8607741 - 财政年份:2013
- 资助金额:
$ 36.31万 - 项目类别:
Nitrites as Antidotes for Hydrogen Sulfide Poisoning
亚硝酸盐作为硫化氢中毒的解毒剂
- 批准号:
8739555 - 财政年份:2013
- 资助金额:
$ 36.31万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 36.31万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 36.31万 - 项目类别:
Operating Grants














{{item.name}}会员




